Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1499 | 2015 |
Epilepsy, suicidality, and psychiatric disorders: a bidirectional association DC Hesdorffer, L Ishihara, L Mynepalli, DJ Webb, J Weil, WA Hauser Annals of neurology 72 (2), 184-191, 2012 | 570 | 2012 |
A systematic review of depression and mental illness preceding Parkinson's disease L Ishihara, C Brayne Acta neurologica scandinavica 113 (4), 211-220, 2006 | 408 | 2006 |
Estimated life expectancy of Parkinson’s patients compared with the UK population LS Ishihara, A Cheesbrough, C Brayne, A Schrag Journal of Neurology, Neurosurgery & Psychiatry 78 (12), 1304-1309, 2007 | 213 | 2007 |
LRRK2 Gly2019Ser penetrance in Arab–Berber patients from Tunisia: a case-control genetic study MM Hulihan, L Ishihara-Paul, J Kachergus, L Warren, R Amouri, R Elango, ... The Lancet Neurology 7 (7), 591-594, 2008 | 185 | 2008 |
Incidence of new-onset seizures in mild to moderate Alzheimer disease MC Irizarry, S Jin, F He, JA Emond, R Raman, RG Thomas, M Sano, ... Archives of neurology 69 (3), 368-372, 2012 | 155 | 2012 |
What is the evidence for a premorbid parkinsonian personality: a systematic review L Ishihara, C Brayne Movement disorders: official journal of the Movement Disorder Society 21 (8 …, 2006 | 152 | 2006 |
Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations L Ishihara, L Warren, R Gibson, R Amouri, S Lesage, A Dürr, M Tazir, ... Archives of neurology 63 (9), 1250-1254, 2006 | 127 | 2006 |
Occurrence and recurrence of attempted suicide among people with epilepsy DC Hesdorffer, L Ishihara, DJ Webb, L Mynepalli, NW Galwey, ... JAMA psychiatry 73 (1), 80-86, 2016 | 102 | 2016 |
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families L Ishihara, RA Gibson, L Warren, R Amouri, K Lyons, C Wielinski, ... Movement Disorders 22 (1), 55-61, 2007 | 92 | 2007 |
PINK1 mutations and parkinsonism L Ishihara-Paul, MM Hulihan, J Kachergus, R Upmanyu, L Warren, ... Neurology 71 (12), 896-902, 2008 | 78 | 2008 |
Sudden unexpected death in epilepsy in lamotrigine randomized‐controlled trials T Tomson, LJ Hirsch, D Friedman, N Bester, A Hammer, M Irizarry, ... Epilepsia 54 (1), 135-140, 2013 | 69 | 2013 |
A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease K Nishioka, M Kefi, B Jasinska-Myga, C Wider, C Vilariño-Güell, OA Ross, ... Journal of Neurology, Neurosurgery & Psychiatry 81 (4), 391-395, 2010 | 62 | 2010 |
The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population P Hobson, J Meara, L Ishihara-Paul Journal of Neurology, Neurosurgery & Psychiatry 81 (10), 1093-1098, 2010 | 61 | 2010 |
A systematic review of nutritional risk factors of Parkinson's disease L Ishihara, C Brayne Nutrition research reviews 18 (2), 259-282, 2005 | 60 | 2005 |
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease L Warren, R Gibson, L Ishihara, R Elango, Z Xue, A Akkari, L Ragone, ... Parkinsonism & related disorders 14 (1), 77-80, 2008 | 40 | 2008 |
The frequency and validity of self-reported diagnosis of Parkinson's Disease in the UK elderly: MRC CFAS cohort T Foltynie, FE Matthews, L Ishihara, C Brayne, ... BMC neurology 6, 1-7, 2006 | 25 | 2006 |
Parkinson's disease case ascertainment in the EPIC cohort: the NeuroEPIC4PD study V Gallo, C Brayne, L Forsgren, RA Barker, J Petersson, O Hansson, ... Neurodegenerative Diseases 15 (6), 331-338, 2015 | 20 | 2015 |
Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa B Jasinska‐Myga, J Kachergus, C Vilariño‐Güell, C Wider, ... Movement Disorders 25 (13), 2052-2058, 2010 | 20 | 2010 |
Physician and pharmacist understanding of the risk of urinary retention with retigabine (ezogabine): a REMS assessment survey L Ishihara, M Beck, S Travis, O Akintayo, N Brickel Drugs-Real World Outcomes 2, 335-344, 2015 | 14 | 2015 |